Oct 30, 2019 - Benchmarks closed in the negative territory on Tuesday due to Alphabet's weak earnings report and uncertainties in timely completion of U.S-China Phase one deal.
Oct 29, 2019 - MRK earnings call for the period ending September 30, 2019.
Oct 29, 2019 -
Oct 29, 2019 - Merck (MRK) delivered earnings and revenue surprises of 20.80% and -99.89%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Oct 29, 2019 - Strong Q3 Earnings Data Deluge
Oct 28, 2019 - Four drug/biotech stocks are scheduled to release third-quarter results on Oct 29. Let's see how these companies are placed before their earnings call.
Oct 28, 2019 - Merck (MRK) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Oct 28, 2019 - Investors will focus on regular top and bottom-line numbers along with updates on the Celgene merger, when Bristol-Myers (BMY) reports third-quarter results.
Oct 24, 2019 - Merck's (MRK) relatively newer products like Keytruda, Gardasil and Bridion are likely to have driven third-quarter sales. However, genericization of key drugs and increased competition are concerns.
Oct 23, 2019 - These stocks have track records of success and plenty of growth ahead.